(Q43724047)

26 November 2017

title

Mechanism of selective inhibition of respiratory syncytial virus by a benzodithiin compound (RD3-0028). (English)

1 reference

26 November 2017

Sudo K

1

1 reference

26 November 2017

Konno K

2

1 reference

26 November 2017

Watanabe W

3

1 reference

26 November 2017

Shigeta S

4

1 reference

26 November 2017

Yokota T

5

1 reference

26 November 2017

publication date

1 January 2001

1 reference

Microbiology and Immunology

26 November 2017

published in

1 reference

26 November 2017

volume

45

1 reference

26 November 2017

issue

7

1 reference

26 November 2017

page(s)

531-537

1 reference

Targeting RNA decay with 2',5' oligoadenylate-antisense in respiratory syncytial virus-infected cells

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2001.TB02654.X

Transcription elongation factor of respiratory syncytial virus, a nonsegmented negative-strand RNA virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2001.TB02654.X

Recombinant human respiratory syncytial virus (RSV) monoclonal antibody Fab is effective therapeutically when introduced directly into the lungs of RSV-infected mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2001.TB02654.X

Kinetics of synthesis of respiratory syncytial virus glycoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2001.TB02654.X

Use of intravenous gamma globulin to passively immunize high-risk children against respiratory syncytial virus: safety and pharmacokinetics. The RSVIG Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2001.TB02654.X

Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The Respiratory Syncytial Virus Immune Globulin Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2001.TB02654.X

Respiratory syncytial virus polypeptides. V. The kinetics of glycoprotein synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2001.TB02654.X

Prospects for a respiratory syncytial virus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2001.TB02654.X

Formulation of the purified fusion protein of respiratory syncytial virus with the saponin QS-21 induces protective immune responses in Balb/c mice that are similar to those generated by experimental infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2001.TB02654.X

In vitro and in vivo inhibition of ortho- and paramyxovirus infections by a new class of sulfonic acid polymers interacting with virus-cell binding and/or fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2001.TB02654.X

Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2001.TB02654.X

Conformational change in a viral glycoprotein during maturation due to disulfide bond disruption

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2001.TB02654.X

Immunoprophylaxis and immunotherapy of respiratory syncytial virus infection in the cotton rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2001.TB02654.X

Safety and pharmacokinetics of an intramuscular humanized monoclonal antibody to respiratory syncytial virus in premature infants and infants with bronchopulmonary dysplasia. The MEDI-493 Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2001.TB02654.X

Antiviral activities of ribavirin, 5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide, and 6'-(R)-6'-C-methylneplanocin A against several ortho- and paramyxoviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2001.TB02654.X

New neplanocin analogues. 1. Synthesis of 6'-modified neplanocin A derivatives as broad-spectrum antiviral agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2001.TB02654.X

Protective epitopes on the fusion protein of respiratory syncytial virus recognized by murine and bovine monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2001.TB02654.X

Analysis of the respiratory syncytial virus fusion protein using monoclonal and polyclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2001.TB02654.X

MTT colorimetric assay system for the screening of anti-orthomyxo- and anti-paramyxoviral agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2001.TB02654.X

Novel anti-respiratory syncytial(RS) viral compounds: benzodithiin derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.2001.TB02654.X

10.1111/J.1348-0421.2001.TB02654.X

21 January 2018

Identifiers

DOI

1 reference

26 November 2017

1 reference